Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment

Malignant Tumor Purity Reveals the Driven and Prognostic Role of CD3E in Low-Grade Glioma Microenvironment

The tumor microenvironment (TME) contributes to the initiation and progression of many neoplasms. However, the impact of low-grade glioma (LGG) purity on carcinogenesis remains to be elucidated. We selected 509 LGG patients with available genomic and clinical information from the TCGA database. The...

Full description

Bibliographic Details
Main Authors:	Xiuqin Lu, Chuanyu Li, Wenhao Xu, Yuanyuan Wu, Jian Wang, Shuxian Chen, Hailiang Zhang, Huadong Huang, Haineng Huang, Wangrui Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Oncology
Subjects:	tumor microenvironment tumor purity CD3E low-grade glioma prognosis immune infiltrations
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.676124/full

Similar Items

Integrating m6A Regulators-Mediated Methylation Modification Models and Tumor Immune Microenvironment Characterization in Caucasian and Chinese Low-Grade Gliomas
by: Wangrui Liu, et al.
Published: (2021-11-01)

Tumor microenvironment in treatment of glioma
by: Li Guijie, et al.
Published: (2017-08-01)

Gasdermin D Plays an Oncogenic Role in Glioma and Correlates to an Immunosuppressive Microenvironment
by: Mengyuan Li, et al.
Published: (2023-05-01)

Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment
by: Yan Zhao, et al.
Published: (2023-06-01)

MYD88 Is a Potential Prognostic Gene and Immune Signature of Tumor Microenvironment for Gliomas
by: Qinglong Guo, et al.
Published: (2021-04-01)

Review: therapeutic approaches for circadian modulation of the glioma microenvironment
by: Ella A. Nettnin, et al.
Published: (2023-12-01)

Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
by: Grant L. Lin, et al.
Published: (2018-06-01)

The miRNA Content of Exosomes Released from the Glioma Microenvironment Can Affect Malignant Progression
by: Federica Caponnetto, et al.
Published: (2020-12-01)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
by: Qiankun Ji, et al.
Published: (2022-05-01)

Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures
by: Yi Xiong, et al.
Published: (2020-01-01)

SYK Is Associated With Malignant Phenotype and Immune Checkpoints in Diffuse Glioma
by: Quanwei Zhou, et al.
Published: (2022-07-01)

Polo-like kinase 1 is related with malignant characteristics and inhibits macrophages infiltration in glioma
by: Lin Luo, et al.
Published: (2022-12-01)

The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
by: Anna Maria Reuss, et al.
Published: (2021-05-01)

Interdependencies of the Neuronal, Immune and Tumor Microenvironment in Gliomas
by: Alexander Yuile, et al.
Published: (2023-05-01)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
by: Wenqian Zhi, et al.
Published: (2023-09-01)

Classification related to immunogenic cell death predicts prognosis, immune microenvironment characteristics, and response to immunotherapy in lower-grade gliomas
by: Yirui Kuang, et al.
Published: (2023-04-01)

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
by: Siliang Chen, et al.
Published: (2022-11-01)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
by: Haiyan Yang, et al.
Published: (2022-10-01)

Comprehensive Characterization of Tumor Purity and Its Clinical Implications in Gastric Cancer
by: Shenghan Lou, et al.
Published: (2022-01-01)

Clinical and Biological Significance of a Necroptosis-Related Gene Signature in Glioma
by: Zunjie Zhou, et al.
Published: (2022-06-01)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
by: Dongming Yan, et al.
Published: (2022-06-01)

Immunomodulatory Effects of Tryptophan Metabolism in the Glioma Tumor Microenvironment
by: Yang Xu, et al.
Published: (2021-10-01)

PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma
by: Peng Li, et al.
Published: (2022-06-01)

Integrated analysis of necroptosis related gene signature to predict clinical outcomes, immune status and drug sensitivity in lower grade Glioma
by: Xiqi Hu, et al.
Published: (2024-01-01)

Autophagy-Dependent Ferroptosis-Related Signature is Closely Associated with the Prognosis and Tumor Immune Escape of Patients with Glioma
by: Sun W, et al.
Published: (2022-01-01)

Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer
by: Mao Y, et al.
Published: (2018-09-01)

Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas
by: Po Zhang, et al.
Published: (2022-03-01)

Classification of Brainstem Gliomas Based on Tumor Microenvironment Status
by: Xiong Xiao, et al.
Published: (2023-08-01)

Glycosylation modification patterns reveal distinct tumor metabolism and immune microenvironment landscape in lower-grade gliomas
by: Guihua Tang, et al.
Published: (2022-08-01)

A Pyroptosis-Related Gene Signature Associated with Prognosis and Tumor Immune Microenvironment in Gliomas
by: Zhou Z, et al.
Published: (2022-05-01)

Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma
by: Wenhao Xu, et al.
Published: (2021-11-01)

The Role of m5C-Related lncRNAs in Predicting Overall Prognosis and Regulating the Lower Grade Glioma Microenvironment
by: Hongshu Zhou, et al.
Published: (2022-03-01)

Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma
by: Wenxia Li, et al.
Published: (2023-02-01)

PD-L2 Serves as a Potential Prognostic Biomarker That Correlates With Immune Infiltration and May Predict Therapeutic Sensitivity in Lower-Grade Gliomas
by: Qijun Xie, et al.
Published: (2022-06-01)

Expression of m6A Regulators Correlated With Immune Microenvironment Predicts Therapeutic Efficacy and Prognosis in Gliomas
by: Shengchao Xu, et al.
Published: (2020-11-01)

Weighted Gene Co-Expression Network Analysis (WGCNA) Reveals the Functions of Syndecan-1 to Regulate Immune Infiltration by Influenced T Cells in Glioma
by: Jiacheng Zhong, et al.
Published: (2022-05-01)

Assessment of MicroRNAs Associated with Tumor Purity by Random Forest Regression
by: Dong-Yeon Nam, et al.
Published: (2022-05-01)

Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma
by: Shengchao Xu, et al.
Published: (2021-09-01)

Recruitment mechanisms and therapeutic implications of tumor-associated macrophages in the glioma microenvironment
by: Xianzhe Zhou, et al.
Published: (2023-04-01)

Cancer Stem Cells and Immunosuppressive Microenvironment in Glioma
by: Qianquan Ma, et al.
Published: (2018-12-01)